Folate, DNA methylation, and mouse models of breast tumorigenesis

Nutrition Reviews

Volumn 66, Issue SUPPL.1, 2008, Pages

  Miller, Joshua W ^a,c   Borowsky, Alexander D ^a,b   Marple, Teresa C ^b   McGoldrick, Erik T ^b   Dillard Telm, Lisa ^b   Young, Lawrence J T ^b   Green, Ralph ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLIC ACID; METHOTREXATE; METHYLENETETRAHYDROFOLIC ACID;

BREAST CANCER; CARCINOGENESIS; COLORECTAL CANCER; CONFERENCE PAPER; DIETARY INTAKE; DNA METHYLATION; DNA SYNTHESIS; FOLATE METABOLISM; FOLIC ACID DEFICIENCY; HUMAN; NONHUMAN; TUMOR GROWTH; VITAMIN SUPPLEMENTATION;

ANIMALS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DIET; DNA METHYLATION; FEMALE; FOLIC ACID; GENE EXPRESSION; GENES, ERBB-2; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE;

EID: 48349097960     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2008.00070.x     Document Type: Conference Paper

References (39)

1. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med. 1999 340 : 1449 1454.
2. Choumenkovitch SF, Jacques PF, Nadeau MR, Wilson PW, Rosenberg IH, Selhub J. Folic acid fortification increases red blood cell folate concentrations in the Framingham study. J Nutr. 2001 131 : 3277 3280.
3. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LYC. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA. 2001 285 : 2981 2986.
4. Ganji V, Kafai MR. Trends in serum folate, RBC folate, and circulating total homocysteine concentrations in the United States: analysis of data from National Health and Nutrition Examination surveys, 1988-1994, 1999-2000, and 2001-2002. J Nutr. 2006 136 : 153 158.
5. Choumenkovitch SF, Selhub J, Wilson PWF, Rader JI, Rosenberg IH, Jacques PF. Folic acid intake from fortification in United States exceeds predictions. J Nutr. 2002 132 : 2792 2798.
6. Kim YI. Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr. 2004 80 : 1123 1128.
7. Mason JB, Dickstein A, Jacques PF, et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev. 2007 16 : 1325 1329.
8. James SJ, Pogribny IP, Pogribna M, Miller BJ, Jernigan S, Melnyk S. Mechanisms of DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of hepatocarcinogenesis. J Nutr. 2003 133 (Suppl S3740 S3747.
9. Kim YI. Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies. Environ Mol Mutagen. 2004 44 : 10 25.
10. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet. 1999 21 : 163 167.
11. Herman JG. Hypermethylation of tumor suppressor genes in cancer. Semin Cancer Biol. 1999 9 : 359 367.
12. Li E, Bird A. DNA methylation in mammals. In : Allis CD, Jenuwein T, Reinberg D, eds. Epigenetics. Cold Spring Harbor, NY : Cold Spring Harbor Laboratory Press 2007 : 341 356.
13. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003 349 : 2042 2054.
14. Baggott JE, Vaughn WH, Juliana MM, Eto I, Krumdieck CL, Grubbs CJ. Effects of folate deficiency and supplementation on methylnitrosourea-induced rat mammary tumors. J Natl Cancer Inst. 1992 84 : 1740 1744.
15. Kotsopoulos J, Sohn K-J, Martin R, et al. Dietary folate deficiency suppresses N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. Carcinogenesis. 2003 24 : 937 944.
16. Kotsopoulos J, Medline A, Renlund R, et al. Effects of dietary folate on the development and progression of mammary tumors in rats. Carcinogenesis. 2005 26 : 1603 1612.
17. Richardson KK, Richardson FC, Crosby RM, Swenberg JA, Skopek TR. DNA base changes and alkylation following in vivo exposure of Escherichia coli to N-methyl-N-nitrosourea or N-ethyl-N-nitrosourea. Proc Natl Acad Sci. 1987 84 : 344 348.
18. Zarbl H, Sukumar S, Arthur AV, Martin-Zanca D, Barbacid M. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature. 1985 315 : 382 385.
19. Cardiff RD, Wagner U, Hennighausen L. Mammary cancer in humans and mice: a tutorial for comparative pathology. Vet Pathol. 2001 38 : 357 358.
20. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol. 1992 12 : 954 961.
21. Muller WJ, Ho J, Siegel PM. Oncogenic activation of Neu/ErbB-2 in a transgenic mouse model for breast cancer. Biochem Soc Symp. 1998 63 : 149 157.
22. Barnes DM, Bartkova J, Camplejohn RS, Gullick WJ, Smith PJ, Millis RR. Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance? Eur J Cancer. 1992 28 : 644 648.
23. Cheng AM, Saxton TM, Sakai R, et al. Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell. 1998 95 : 793 803.
24. Markland W, Cheng SH, Oostra BA, Smith AE. In vitro mutagenesis of the putative membrane-binding domain of polyomavirus middle-T antigen. J Virol. 1986 59 : 82 89.
25. Cardiff RD, Munn RJ. The histopathology of transgenes and knockouts in the mammary gland. In : Heppner G, ed. Advances in Oncobiology. Greenwich, CT : JAI Press Inc 1998 : 177 202.
26. Miller JW, Borowsky AD, McGoldrick ET, Green R. Methyl deficiency slows the proliferation of breast tumors in FVB polyoma middle T (PyV-mT) transgenic mice. FASEB J. 2005 19 : A420 A421.
27. Sanders ME, Schuyler PA, Dupont WD, Page DL. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer. 2005 103 : 2481 2484.
28. Simpson JF, Page DL. The role of pathology in premalignancy and as a guide for treatment and prognosis in breast cancer. Semin Oncol. 1996 23 : 428 435.
29. Fonseca R, Hartmann LC, Petersen IA, Donohue JH, Crotty TB, Gisvold JJ. Ductal carcinoma in situ of the breast. Ann Intern Med. 1997 127 : 1013 1022.
30. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer. 1982 50 : 1309 1314.
31. Cardiff RD. The biology of mammary transgenes: five rules. J Mammary Gland Biol Neoplasia. 1996 1 : 61 73.
32. Maglione JE, Moghanaki D, Young LJ, et al. Transgenic polyoma middle-T mice model premalignant mammary disease. Cancer Res. 2001 61 : 8298 8305.
33. Maglione JE, McGoldrick ET, Young LJ, et al. Polyomavirus middle T-induced mammary intraepithelial neoplasi outgrowths: single origin, divergent evolution, and multiple outcomes. Mol Cancer Ther. 2004 3 : 941 953.
34. Namba R, Maglione JE, Young LJ, et al. Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ. Mol Cancer Res. 2004 2 : 453 463.
35. Ma XJ, Salunga R, Tuggle JT, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci 2003 100 : 5974 5979.
36. Borowsky AD, Namba R, Young LJ, et al. Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. Clin Exp Metastasis. 2005 22 : 47 59.
37. Qui TH, Chandramouli GV, Hunter KW, Alkharouf NW, Green JE, Liu ET. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease. Cancer Res. 2004 64 : 5973 5981.
38. Namba R, Young LJ, Abbey CK, et al. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of DCIS. Clin Cancer Res. 2006 12 : 2613 2621.
39. Abbey CK, Borowsky AD, McGoldrick ET, et al. In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia. PNAS. 2004 101 : 11438 11443.